Intelligence Platform
Patents
Browse 2,828 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 6462042
Hydroxamic acid derivatives as matrix metalloproteinase (mmp) inhibitors
expired patentUS 6455541
Suppression, by 5-lipoxygenase inhibitors, of bone resorption
expired patentUS 6448238
Inhibitors of &bgr;-lactamases and uses therefor
expired patentUS 6444695
Inhibition of thrombin-induced platelet aggregation by creatine kinase inhibitors
expired patentUS 6436989
Prodrugs of aspartyl protease inhibitors
expired patentUS 6436980
Peptidomimetic efflux pump inhibitors
expired patentUS 6426413
Inhibitors of caspases
expired patentUS 6423840
Inhibitors of interleukin-1&bgr; converting enzyme
expired patentUS 6420522
Inhibitors of interleukin-1&bgr; converting enzyme
expired patentUS 6417174
Inhibitors of &bgr;-lactamases and uses therefor
expired patentUS 6414132
Method of eliminating inhibitory/instability regions of mRNA
expired patentUS 6413773
Phosphatidylinositol 3-kinase inhibitors as stimulators of endocrine differentiation
expired patentUS 6410747
Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzhe
expired patentUS 6410594
Substituted cyclopentane compounds useful as neuraminidase inhibitors
expired patentUS 6407080
N-(pyrimidinyl)-aspartic acid analogs as interleukin-1&bgr; converting enzyme inhibitors
expired patentUS 6399639
Apoptosis inhibitor
expired patentUS 6399633
Use of 4-H-1-benzopryan-4-one derivatives as inhibitors of smooth muscle cell proliferatio
expired patentUS 6399627
Inhibitors of factor Xa
expired patentUS 6395763
Prodrugs of carbamate inhibitors of IMPDH
expired patentUS 6392046
Sulfonamide inhibitors of aspartyl protease
expired patentUS 6391909
Anandamide inhibitors as analgesic agents
expired patentUS 6387923
Imminoribitol PNP inhibitors, preparation thereof and use thereof
expired patentUS 6383790
High affinity protein kinase inhibitors
expired patentUS 6376515
Benzamides and related inhibitors of factor Xa
expired